Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
301331 Enwei Pharmaceutical
- 26.50
- +0.84+3.27%
Market Closed Dec 12 15:00 CST
2.73BMarket Cap77.03P/E (TTM)
27.33High25.54Low31.88KlotVolume25.66Open25.66Pre Close84.35MTurnover9.63%Turnover Ratio31.59P/E (Static)102.89MShares32.5052wk High2.67P/B877.20MFloat Cap18.5252wk Low30.79Limit Up33.10MShs Float39.28Historical High20.53Limit Down6.98%Amplitude18.52Historical Low0.55Dividend TTM26.46Avg Price14.52KlotAsk2.06%Div YieldTTM100Lot Size14.29KlotBid
Enwei Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.67%560.34M | -1.80%388.15M | -8.63%183.48M | 13.54%785.19M | 17.93%569.89M | 18.06%395.25M | 27.41%200.8M | 1.75%691.57M | -0.72%483.24M | 0.47%334.78M |
| Operating revenue | -1.67%560.34M | -1.80%388.15M | -8.63%183.48M | 13.54%785.19M | 17.93%569.89M | 18.06%395.25M | 27.41%200.8M | 1.75%691.57M | -0.72%483.24M | 0.47%334.78M |
| Other operating revenue | ---- | 25.91%2.4M | ---- | -2.09%3.99M | ---- | -2.51%1.9M | ---- | 4.15%4.07M | ---- | -1.51%1.95M |
| Total operating cost | 7.54%534.87M | 9.97%365.61M | 3.55%174.12M | 12.55%698.33M | 14.45%497.38M | 14.17%332.47M | 25.43%168.14M | 6.92%620.48M | 4.64%434.59M | 4.05%291.2M |
| Operating cost | -2.39%274.84M | -2.98%186.8M | -3.07%91.26M | 11.12%382.74M | 13.72%281.56M | 18.57%192.54M | 24.78%94.15M | 16.07%344.43M | 14.14%247.59M | 13.28%162.38M |
| Operating tax surcharges | 24.30%9.45M | 22.31%6.47M | -8.12%2.54M | 10.15%10.89M | -13.30%7.6M | -12.03%5.29M | 1.75%2.76M | -15.06%9.89M | 14.87%8.77M | 21.72%6.01M |
| Operating expense | 17.78%187.71M | 26.11%132.08M | 3.18%60.9M | 17.13%234.85M | 18.09%159.37M | 9.52%104.73M | 36.32%59.02M | -4.45%200.51M | -7.58%134.95M | -5.33%95.63M |
| Administration expense | 47.97%58.13M | 46.11%37.26M | 52.36%18.21M | -0.07%59.43M | 0.17%39.28M | 0.77%25.5M | 2.37%11.95M | 4.30%59.48M | -4.82%39.22M | -8.99%25.31M |
| Financial expense | 81.17%-1.02M | 90.05%-363.86K | 78.31%-406.99K | -378.82%-6.41M | -1,213.46%-5.4M | -2,594.75%-3.66M | -4,471.44%-1.88M | -282.31%-1.34M | -238.93%-411.15K | -122.48%-135.75K |
| -Interest expense (Financial expense) | --1.48M | --568.77K | --144.38K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Interest Income (Financial expense) | 48.78%-2.83M | 67.17%-1.24M | 69.51%-590.39K | -369.46%-6.56M | -1,225.58%-5.53M | -1,876.26%-3.77M | -2,369.01%-1.94M | -169.67%-1.4M | 5.02%-417.02K | 37.46%-190.52K |
| Research and development | -61.44%5.77M | -58.26%3.37M | -23.99%1.62M | 123.71%16.82M | 234.70%14.97M | 301.95%8.07M | 124.73%2.13M | 73.81%7.52M | 38.85%4.47M | -6.50%2.01M |
| Credit Impairment Loss | 67.89%-511.94K | -38.66%-1.68M | 43.86%-383.15K | 76.09%-403.35K | 20.42%-1.59M | 18.02%-1.21M | 10.40%-682.51K | -481.64%-1.69M | -78.50%-2M | -41.66%-1.48M |
| Asset Impairment Loss | -1,214.28%-1.23M | -5,207.93%-1.18M | -1,266.18%-538.02K | -577.81%-179.52K | 323.83%109.99K | 93.52%-22.21K | 81.92%-39.38K | -83.52%37.57K | 91.48%-49.14K | -23.50%-342.71K |
| Other net revenue | -75.24%3.06M | -92.80%808.61K | -23.26%1.13M | 37.56%14.86M | 44.63%12.37M | 1,632.24%11.22M | 446.23%1.48M | -45.42%10.8M | 19.76%8.55M | 410.56%647.91K |
| Invest income | -16.57%2.4M | -10.22%1.85M | -0.81%1.06M | 533.90%3.74M | 2,876.66%2.88M | 2,500.71%2.06M | --1.07M | 235.55%590.48K | 79.17%-103.62K | 82.28%-85.78K |
| -Including: Investment income associates | -476.97%-43.54K | 50.58%6.02K | ---- | 132.79%21.84K | 111.15%11.55K | 104.66%4K | ---- | 84.71%-66.61K | 79.17%-103.62K | 82.28%-85.78K |
| Asset deal income | -304.75%-166.77K | -195.90%-121.92K | -90.68%-78.57K | ---40.98K | ---41.2K | ---41.2K | ---41.2K | --0 | ---- | --0 |
| Other revenue | -76.70%2.57M | -81.39%1.94M | -8.36%1.08M | -1.01%11.74M | 2.87%11.01M | 308.51%10.44M | 112.44%1.17M | -41.54%11.86M | 14.68%10.71M | 32.22%2.56M |
| Operating profit | -66.38%28.53M | -68.45%23.35M | -69.26%10.49M | 24.22%101.73M | 48.37%84.87M | 67.31%74M | 47.60%34.14M | -31.28%81.9M | -27.19%57.2M | -17.31%44.23M |
| Add:Non operating Income | -23.45%211.69K | -39.24%6.12K | --0 | -30.42%284.48K | -30.91%276.53K | -97.48%10.07K | -64.33%10.07K | 1,720.51%408.85K | 1,682.17%400.24K | 1,682.17%400.24K |
| Less:Non operating expense | 17,231.71%3.22M | 2,207.22%417.36K | --571.95 | 57.54%696.59K | -95.65%18.59K | 289.36%18.09K | --0 | 496.08%442.17K | 495.25%427.71K | -84.34%4.65K |
| Total profit | -70.02%25.52M | -69.00%22.94M | -69.27%10.49M | 23.76%101.31M | 48.89%85.13M | 65.81%73.99M | 47.47%34.15M | -31.28%81.86M | -27.18%57.18M | -16.56%44.62M |
| Less:Income tax cost | -71.30%3.5M | -50.12%5M | -68.08%2.07M | 6.69%15M | 57.88%12.2M | 84.46%10.03M | 123.60%6.48M | -19.16%14.06M | -40.72%7.73M | -39.59%5.44M |
| Net profit | -69.81%22.02M | -71.96%17.93M | -69.56%8.42M | 27.30%86.31M | 47.49%72.93M | 63.22%63.96M | 36.58%27.67M | -33.35%67.8M | -24.48%49.45M | -11.91%39.19M |
| Net profit from continuing operation | -69.81%22.02M | -71.96%17.93M | -69.56%8.42M | 27.30%86.31M | 47.49%72.93M | 63.22%63.96M | 36.58%27.67M | -33.35%67.8M | -24.48%49.45M | -11.91%39.19M |
| Net profit of parent company owners | -69.81%22.02M | -71.96%17.93M | -69.56%8.42M | 27.30%86.31M | 47.49%72.93M | 63.22%63.96M | 36.58%27.67M | -33.35%67.8M | -24.48%49.45M | -11.91%39.19M |
| Earning per share | ||||||||||
| Basic earning per share | -69.21%0.2183 | -71.54%0.1769 | -69.07%0.122 | 3.52%1.2317 | -24.60%0.7089 | -16.56%0.6216 | 2.44%0.3945 | -38.49%1.1898 | -24.48%0.9402 | -11.89%0.745 |
| Diluted earning per share | -69.40%0.2169 | -71.69%0.176 | -69.10%0.1219 | 3.50%1.2315 | -24.60%0.7089 | -16.56%0.6216 | 2.44%0.3945 | -38.49%1.1898 | -24.48%0.9402 | -11.89%0.745 |
| Other composite income | ||||||||||
| Total composite income | -69.81%22.02M | -71.96%17.93M | -69.56%8.42M | 27.30%86.31M | 47.49%72.93M | 63.22%63.96M | 36.58%27.67M | -33.35%67.8M | -24.48%49.45M | -11.91%39.19M |
| Total composite income of parent company owners | -69.81%22.02M | -71.96%17.93M | -69.56%8.42M | 27.30%86.31M | 47.49%72.93M | 63.22%63.96M | 36.58%27.67M | -33.35%67.8M | -24.48%49.45M | -11.91%39.19M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
